Multiple projects have been jointly
developed between INS and CDC, including enhanced surveillance of
pregnant women with symptomatic Zika virus disease. CDC seeks to
implement a prospective cohort study in which we will follow women
enrolled in the first trimester of pregnancy, their male partners,
and their children in several cities in Colombia in which ZIKV
transmission is currently ongoing. This is a continuation study to
collect data on the OMB-approved Emergency Clearance package
0920-1142, and the Standard ICR 0920-1190, which covered collection
of infants out to six months old. This Revision ICR will collect
information on infants from 6 months out to two years after
birth.
Submission of this Revision for
0920-1190 ZEN Colombia Study: Zika in Pregnant Women and Children
in Colombia reflects 1) decrease in burden hours because of
lowering number of remaining respondents to 500 pregnant women and
125 male partners during the pregnancy follow-up, as enrollment is
progressing, and 2) increase in burden hours with the addition of
data collection to follow 900 children from 6 months to 2 years of
age
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.